000788，董事长被刑拘！

Core Points - The chairman and president of Beijing University Pharmaceutical, Xu Xiren, has been criminally detained and is temporarily unable to perform his duties [1] - The company has stated that its control has not changed and that its board of directors is operating normally [2] - Xu Xiren remains the actual controller of the company despite his detention [2] Company Control and Management - The company has made arrangements for its operations, with Xu Xiren authorizing other executives to perform his duties during his absence [2] - Xu Xiren acquired control of Beijing University Pharmaceutical through a transaction in December 2024, purchasing the controlling stake for 1 yuan while assuming significant debts [3] - Xu Xiren has held the positions of actual controller, chairman, and president of the company since his appointment in July 2025 [4] Financial Performance - In the first half of 2025, the company reported revenues of 957 million yuan, a year-on-year decrease of 5.04%, while net profit attributable to shareholders reached 100 million yuan, an increase of 15.51% [4] - The termination of a long-term service contract with Peking University International Hospital in April 2025 is expected to reduce the company's sales revenue and net profit in the second half of 2025 [4] Market Reaction - As of October 29, the company's stock price closed at 6.17 yuan per share, with a total market capitalization of 3.677 billion yuan [5]